Showing results (121-130 of 193) with videos related to

Sort By:
Pageof 20
Plos One|August 28, 2015
Is Hemoglobin Level in Patients with Nasopharyngeal Carcinoma Still a Significant Prognostic Factor in the Era of Intensity-Modulated Radiotherapy Technology?Shan-Shan Guo, Lin-Quan Tang, Qiu-Yan Chen, et al.
BMC Cancer|January 23, 2019
Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein-Barr virus DNA level and tumor response to palliative chemotherapyXue-Song Sun, Li-Ting Liu, Sai-Lan Liu, et al.
The Oncologist|June 27, 2025
Anti-PD-1 antibody with or without capecitabine as maintenance therapy after first-line therapy of recurrent or metastatic nasopharyngeal carcinomaYi-Fu Li, Yu Chen, Hui Cheng, et al.
Frontiers in Oncology|April 9, 2020
Intensive Local Radiotherapy Is Associated With Better Local Control and Prolonged Survival in Bone-Metastatic Nasopharyngeal Carcinoma PatientsXiao-Yun Li, Guo-Dong Jia, Xue-Song Sun, et al.
Oncotarget|October 30, 2015
Combining plasma Epstein-Barr virus DNA and nodal maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography improved prognostic stratification to predict distant metastasis for locoregionally advanced nasopharyngeal carcinomaWen-Hui Chen, Lin-Quan Tang, Lu Zhang, et al.
Oral Oncology|April 17, 2022
Cost-Effectiveness analysis of combining plasma Epstein-Barr virus DNA testing and different surveillance imaging modalities for nasopharyngeal carcinoma patients in first remissionZhen-Chong Yang, Zhi-Qiang Nie, Qiu-Yan Chen, et al.
Cancer Medicine|June 19, 2019
Individualized concurrent chemotherapy by pretreatment plasma Epstein-Barr viral DNA in II-III stage nasopharyngeal carcinoma: A propensity score matching analysis using a large cohortXue-Song Sun, Wen-Hui Chen, Sai-Lan Liu, et al.
Frontiers in Public Health|December 19, 2024
Prevalence of mental disorders and their associations with age at diagnosis and time since diagnosis of nasopharyngeal cancerWen-Xuan Wang, Yi-Shan Wu, Li-Ping Qi, et al.
Nature Communications|January 31, 2024
Toripalimab plus capecitabine in the treatment of patients with residual nasopharyngeal carcinoma: a single-arm phase 2 trialXun Cao, Hao-Yang Huang, Chi-Xiong Liang, et al.
Oral Oncology|June 11, 2019
Establishment and validation of a nomogram for predicting survival in patients with de novo metastatic nasopharyngeal carcinomaXue-Song Sun, Yu-Jing Liang, Sai-Lan Liu, et al.
Pageof 20